Patents by Inventor Barbara Kahn

Barbara Kahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060089320
    Abstract: The invention provides methods for modulating type II? phosphoinisitide phosphate kinase (PIPKII?) activity for treating PIPKII?-associated disorders. The invention also provides methods of identifying candidate agents for treating PIPKII?-associated disorders.
    Type: Application
    Filed: February 3, 2003
    Publication date: April 27, 2006
    Inventors: Lewis Cantley, Katja Lamia, Lucia Rameh, Barbara Kahn, Odile Peroni
  • Publication number: 20050208535
    Abstract: Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
    Type: Application
    Filed: December 10, 2004
    Publication date: September 22, 2005
    Inventors: Barbara Kahn, Qin Yang, Tim Graham, Odile Peroni
  • Publication number: 20050158310
    Abstract: The invention features methods and compositions for modulating weight or fat content in a subject. The method includes modulating insulin receptor signaling in an adipocyte tissue of the subject, wherein insulin receptor signaling is preferably not substantially modulated in a non-adipocyte tissue of the subject.
    Type: Application
    Filed: September 22, 2004
    Publication date: July 21, 2005
    Applicants: Joslin Diabetes Center, Inc., Beth Israel Deaconess Medical Center, Inc.
    Inventors: Ronald Kahn, Barbara Kahn
  • Patent number: D270002
    Type: Grant
    Filed: June 26, 1981
    Date of Patent: August 2, 1983
    Inventors: Donald E. Kahn, Barbara Kahn